Annual Results Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
EQUITY AND LIABILITIES
No of Months
12
12
Share Capital
5.47
4.72
Share Warrants & Outstandings
Total Reserve
258.73
136.66
Shareholder's Funds
278.11
141.38
Minority Interest
0.00
0.00
Long-Term Borrowings
56.31
9.61
Secured Loans
56.31
9.61
Unsecured Loans
0.00
0.00
Deferred Tax Assets / Liabilities
6.55
4.48
Other Long Term Liabilities
0
0
Long Term Trade Payables
0.00
0.00
Long Term Provisions
4.26
3.83
Total Non-Current Liabilities
67.11
17.93
Current Liabilities
Trade Payables
87.58
144.77
Other Current Liabilities
43.19
25.80
Short Term Borrowings
166.09
157.53
Short Term Provisions
0.00
0.00
Total Current Liabilities
296.86
328.10
Total Liabilities
642.08
487.41
ASSETS
Non-Current Assets
0.00
0.00
Gross Block
148.12
74.53
Less: Accumulated Depreciation
29.86
21.61
Less : Impairment of Assets
0.00
0.00
Net Block
118.26
52.92
Lease Adjustment
0.00
0.00
Capital Work in Progress
0.00
0.00
Intangible assets under development
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
Assets in transit
0.00
0.00
Non Current Investments
2.01
1.50
Long Term Loans & Advances
12.43
5.03
Other Non Current Assets
11.21
0.76
Total Non-Current Assets
143.91
60.21
Current Assets Loans & Advances
Current Investments
0.00
0.00
Inventories
269.80
239.89
Sundry Debtors
92.69
177.12
Cash and Bank
64.98
5.22
Other Current Assets
7.08
3.14
Short Term Loans and Advances
63.62
1.83
Total Current Assets
498.17
427.20
Net Current Assets (Including Current Investments)
201.31
99.11
Total Current Assets Excluding Current Investments
498.17
427.20
Miscellaneous Expenses not written off
0.00
0.00
Total Assets
642.08
487.41
Contingent Liabilities
0.00
0.00
Total Debt
222.40
167.15
Book Value per share (adjusted)
0
0
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 33.05% vs NA in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 0.00% vs NA in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 123.47% vs NA in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 34.00% vs NA in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 16.61% vs NA in Mar 2025
Compare Balance Sheet Results of Fredun Pharma
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.47
68.74
-63.27
-92.04%
Share Warrants & Outstandings
Total Reserve
258.73
1,030.16
-771.43
-74.88%
Shareholder's Funds
278.11
1,173.00
-894.89
-76.29%
Minority Interest
0.00
-0.03
0.03
100.00%
Long-Term Borrowings
56.31
25.71
30.60
119.02%
Secured Loans
56.31
6.38
49.93
782.60%
Unsecured Loans
0.00
19.33
-19.33
-100.00%
Deferred Tax Assets / Liabilities
6.55
-44.64
51.19
114.67%
Other Long Term Liabilities
0.00
7.72
-7.72
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
4.26
11.37
-7.11
-62.53%
Total Non-Current Liabilities
67.11
0.15
66.96
44,640.00%
Current Liabilities
Trade Payables
87.58
110.23
-22.65
-20.55%
Other Current Liabilities
43.19
93.61
-50.42
-53.86%
Short Term Borrowings
166.09
14.91
151.18
1,013.95%
Short Term Provisions
0.00
1.83
-1.83
-100.00%
Total Current Liabilities
296.86
220.58
76.28
34.58%
Total Liabilities
642.08
1,393.70
-751.62
-53.93%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
148.12
651.23
-503.11
-77.26%
Less: Accumulated Depreciation
29.86
381.67
-351.81
-92.18%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
118.26
269.56
-151.30
-56.13%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.01
176.35
-174.34
-98.86%
Long Term Loans & Advances
12.43
81.25
-68.82
-84.70%
Other Non Current Assets
11.21
0.00
11.21
0.00%
Total Non-Current Assets
143.91
528.35
-384.44
-72.76%
Current Assets Loans & Advances
Current Investments
0.00
39.37
-39.37
-100.00%
Inventories
269.80
114.18
155.62
136.29%
Sundry Debtors
92.69
164.52
-71.83
-43.66%
Cash and Bank
64.98
428.04
-363.06
-84.82%
Other Current Assets
7.08
38.79
-31.71
-81.75%
Short Term Loans and Advances
63.62
80.45
-16.83
-20.92%
Total Current Assets
498.17
865.35
-367.18
-42.43%
Net Current Assets (Including Current Investments)
201.31
644.77
-443.46
-68.78%
Total Current Assets Excluding Current Investments
498.17
825.98
-327.81
-39.69%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
642.08
1,393.70
-751.62
-53.93%
Contingent Liabilities
0.00
0.11
-0.11
-100.00%
Total Debt
222.40
40.61
181.79
447.65%
Book Value per share (adjusted)
0.00
159.86
-159.86
-100.00%
Annual - Borrowings
Borrowings 222.40 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 33.05% vs NA in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs NA in Mar 2025
Annual - Fixed Assets
Fixed Assets 118.26 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 123.47% vs NA in Mar 2025
Annual - Investments
Investments 2.01 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 34.00% vs NA in Mar 2025
Annual - Current Assets
Current Assets 498.17 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 16.61% vs NA in Mar 2025
